Price Reduction Pressure from Procurement + Demand Decline Pressure from Digital Imaging Penetration
The global medical thermal dry image film market finds itself at a critical inflection point in 2026, confronting unprecedented dual pressures that are reshaping the industry landscape. On one front, aggressive centralized procurement initiatives across major markets—particularly in China—have driven substantial price reductions for medical thermal dry image film, compressing manufacturer margins. On the other front, accelerating digital imaging penetration, fueled by widespread PACS adoption and cloud-based solutions, continues to erode traditional consumption volumes of this diagnostic medium. Industry analysts characterize this convergence as the most significant challenge facing the sector since the transition from wet to dry processing. The global market, valued at approximately $1.38 billion in 2025, now faces an uncertain trajectory as these opposing forces—cost pressure and demand erosion—intensify simultaneously.
The price reduction pressure stems primarily from large-scale centralized procurement programs that have fundamentally altered the pricing dynamics for diagnostic dry film. China‘s Beijing-Tianjin-Hebei “3+N” alliance, representing one of the most comprehensive regional purchasing coalitions, recently concluded a landmark procurement covering 2,466 product specifications of medical thermal dry image film, with 95 companies winning bids. The resulting price ranges tell a stark story: laser film prices fell to 3-14.68 yuan per sheet, while thermal film dropped to 2.17-8.88 yuan per sheet. In some procurement rounds, Type I products reached prices as low as 5.18 yuan per sheet, with Type II falling to 4.07 yuan. Earlier alliance procurements achieved average price reductions of 62.3 percent for medical dry film products, with some specifications seeing declines as steep as 92.4 percent. These aggressive price reductions have delivered substantial savings for healthcare systems—China‘s annual consumption of 650 million sheets of medical film, valued at nearly RMB 6 billion—but have simultaneously squeezed manufacturer profitability to precarious levels.
The demand decline pressure presents an equally formidable challenge for the industry. Digital imaging systems, particularly Picture Archiving and Communication Systems, have achieved near-universal adoption in developed healthcare markets, fundamentally reducing the clinical scenarios requiring physical output from medical thermal dry image film. The global PACS market, valued at approximately $4.43 billion in 2025, continues its strong growth trajectory with a CAGR of 9.1 percent. Cloud-based medical imaging solutions, valued at $911 million in 2024, are projected to reach $1.56 billion by 2031 at an 8.0 percent CAGR, further diminishing reliance on physical media. Industry data reveals that the broader medical X-ray film market is projected to decline from $800-850 million in 2025 to approximately $550-600 million by 2030, reflecting a negative CAGR of -8 percent to -7 percent. Agfa-Gevaert, a bellwether for the sector, reported that its medical film revenues declined by nearly 20 percent in Q3 2025, with the company describing a “continued fast decline of the medical film markets, particularly in China.”
The simultaneous impact of these dual pressures is forcing fundamental reassessment across the value chain. Manufacturers must now navigate a landscape where procurement-driven price erosion reduces per-unit margins precisely as digital substitution reduces overall volume. This combination—lower prices on fewer units—creates a profit squeeze that threatens the viability of less efficient producers. Industry observers note that consolidation among manufacturers of medical thermal dry image film is accelerating, with smaller players struggling to maintain profitability amid the converging pressures. Larger producers are diversifying their portfolios toward premium, application-specific products that command higher margins and face less procurement pressure. Some are expanding into complementary digital solutions, offering integrated physical and cloud service packages to maintain customer relationships as workflows hybridize.
Regional dynamics reveal divergent trajectories for demand. The Asia-Pacific region, while representing the fastest-growing market with a projected 15.2 percent CAGR through 2031, simultaneously experiences the most aggressive procurement-driven price compression. China‘s centralized purchasing programs for medical thermal dry image film have set new pricing benchmarks that ripple across global markets. North America and Europe, with higher digitalization penetration, face demand decline pressures more acutely, though consumption persists in specialized applications such as surgical planning, trauma care, and legal documentation. The Middle East and Africa, along with Latin America, present pockets of growth as healthcare infrastructure expands, though volumes remain modest compared to mature markets.
Despite these pressures, certain use cases continue to sustain demand for medical thermal dry image film. Multidisciplinary team meetings, surgical planning, and patient consultations still benefit from tangible copies that can be annotated and shared without digital infrastructure. Regulatory requirements in many jurisdictions mandate physical records for specific imaging studies, ensuring baseline consumption. The installed base of dry imagers compatible exclusively with this medium represents a significant switching cost for hospitals, providing a measure of market protection. However, analysts caution that as PACS and cloud solutions achieve deeper penetration—particularly in emerging markets where consumption has historically been strongest—these protective factors will diminish over time.
Strategic responses from manufacturers increasingly focus on operational efficiency and value-added services. Cost optimization programs have become essential for producers to maintain profitability amid procurement-driven price erosion. Some manufacturers are investing in silver-free and reduced-silver formulations of medical thermal dry image film that reduce raw material costs while appealing to environmentally conscious healthcare providers. Others are developing integrated solutions that combine physical media with digital workflow tools, positioning the product as one component of broader imaging ecosystems rather than a standalone commodity. The transition toward hybrid imaging solutions—where this film is used selectively within predominantly digital workflows—represents a strategic adaptation that preserves market presence while acknowledging digital realities.
Looking beyond 2026, the long-term outlook for medical thermal dry image film depends on how effectively the industry navigates these dual pressures. Market forecasts suggest the global market will maintain modest growth, with projections ranging from $1.67 billion by 2032 to $2.07 billion by 2031, representing CAGRs of 5-7 percent. However, these aggregate figures mask significant compositional shifts: volume growth in emerging markets may be offset by price erosion and digital substitution in mature markets. The industry‘s ability to innovate—through cost-efficient manufacturing, environmentally sustainable formulations, and integrated digital-physical solutions—will determine whether the RMB 10.2 billion market represents a plateau or a foundation for continued relevance. As one industry executive noted, the sector must “optimize the cost base of traditional film activities” while simultaneously investing in capabilities that address evolving clinical needs.
In conclusion, the global medical thermal dry image film market in 2026 faces a defining moment as procurement-driven price reduction and digitalization-driven demand decline converge with unprecedented force. The aggressive centralized purchasing programs that have driven prices down by over 60 percent in some markets, combined with PACS adoption that continues eroding traditional consumption volumes, create a challenging operating environment for manufacturers and suppliers. Yet the enduring clinical value of physical imaging media—durability, portability, and independence from digital infrastructure—ensures that medical thermal dry image film will retain a role in hybrid diagnostic workflows. The industry‘s response to these dual pressures will shape not only the market‘s trajectory but also the broader evolution of diagnostic imaging, where digital and physical media increasingly coexist in service of accurate diagnosis and optimal patient care. This sector must adapt, innovate, and transform to maintain its relevance in an increasingly digital healthcare landscape.